Results 151 to 160 of about 33,833,464 (200)

MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian Cancer. [PDF]

Cancer Res Commun
Williams I, O'Malley M, DeHart H, Walker B, Ulhaskumar V, Jothirajah P, Ray H, Landrum LM, Delaney JR, Nephew KP, Carpenter RL.   +10 more
europepmc   +1 more source

Fine-tuning probes for fluorescence polarization binding assays of bivalent ligands against polo-like kinase 1 using full-length protein. [PDF]

Bioorg Med Chem
Tsuji K, Tamamura H, Burke TR.
europepmc   +1 more source

Upregulation of phosphatase and tensin homolog deleted on chromosome ten inhibits lung cancer cell proliferation by suppressing the oncogene polo-like kinase 1 and inducing autophagy. [PDF]

Cytojournal
Jiang W, Wang P, Huang L.
europepmc   +1 more source

A polo-like kinase 1 inhibitor enhances erastin sensitivity in head and neck squamous cell carcinoma cells in vitro. [PDF]

Cancer Chemother Pharmacol
Wu X, Wu J.
europepmc   +1 more source

Sterile Alpha Motif Domain-Containing 5 Suppresses Malignant Phenotypes and Tumor Growth in Breast Cancer: Regulation of Polo-Like Kinase 1 and c-Myc Signaling in a Xenograft Model. [PDF]

Cureus
Tuo Y, Ye Y.
europepmc   +1 more source

Polo-like Kinase 1 Predicts Lymph Node Metastasis in Middle Eastern Colorectal Cancer Patients; Its Inhibition Reverses 5-Fu Resistance in Colorectal Cancer Cells. [PDF]

Cells
Poyil PK, Siraj AK, Padmaja D, Parvathareddy SK, Alobaisi K, Thangavel S, Begum R, Diaz R, Al-Dayel F, Al-Kuraya KS.   +9 more
europepmc   +1 more source

Affinity enhancement of polo-like kinase 1 polo box domain-binding ligands by a bivalent approach using a covalent kinase-binding component. [PDF]

RSC Chem Biol
Tsuji K, Tamamura H, Burke TR.
europepmc   +1 more source

Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program. [PDF]

Am J Pathol
Weiss J, Gibbons K, Ehyaee V, Perez-Silos V, Zevallos A, Maienschein-Cline M, Brister E, Sverdlov M, Shah E, Balakrishna J, Symes E, Frederiksen JK, Gann PH, Post R, Lopez-Hisijos N, Reneau J, Venkataraman G, Bailey N, Brown NA, Xu ML, Wilcox RA, Inamdar K, Murga-Zamalloa C.   +22 more
europepmc   +1 more source

Correction for Park et al., Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

KIF2A Upregulates PI3K/AKT Signaling through Polo-like Kinase 1 (PLK1) to Affect the Proliferation and Apoptosis Levels of Eriocheir sinensis Spermatogenic Cells. [PDF]

Biology (Basel)
Zhao YS, Liu DX, Tan FQ, Yang WX.
europepmc   +1 more source